News

Enter your email address to get Core One Labs News Alerts.
Company News
March 09, 2021
Core One Labs In Collaboration with KICT To Explore DMT Assisted Psychotherapy
Vancouver, British Columbia, Canada – March 9, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce...
Read more
Company News
March 04, 2021
Core One Labs’ Subsidiary Vocan to Work with Former Canopy CEO Mr. Marcelo Galvão to License Biosynthesized Psilocybin in Brazil
Vancouver, British Columbia, Canada – March 4, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce...
Read more
Company News
February 26, 2021
Core One Labs Initiates First Strain Production for Biosynthetic Psilocybin
Vancouver, British Columbia, Canada – February 26, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”) a biotechnology research...
Read more
Company News
February 24, 2021
Core One Labs Finalizes Deal to Acquire Ketamine Infusions Centers of Texas, Entering the US Market for Psychedelic Treatments
Vancouver, British Columbia, Canada – February 23, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”) a research and technology company focused...
Read more
Company News
February 10, 2021
Core One Labs Highlights Key Points From International Investor Call
Vancouver, British Columbia, Canada – February 10, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (“Core One” the “Company”)...
Read more
Company News
February 10, 2021
Core One Labs Prepares First in Series of Patent Applications
Vancouver, British Columbia, Canada – February 10, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core...
Read more